These results align with an earlier study, which revealed that Bevacizumab reduced ALT and AST levels and ameliorated hepatic fibrosis in an animal model of liver fibrosis, suggesting that it could protect from sepsis-induced damage [16]. This evidence concerns the gene GPT and Sepsis.